Although GATA-binding transcription factors (GATA-1 and GATA-2) are strongly expressed in cultured mast cells (CMCs), their expression in mast cells within tissues has not been reported. We examined the expression of GATA-1 and GATA-2 in skin tissues of mice using Northern blot analysis and in situ hybridization. mRNA for GATA-2 but not for GATA-1 was expressed in skin mast cells of WB-+/+ embryos between days 15 and 17 postcoitum (pc). The expression was downregulated on and after day 18 pc. Skin mast cells did not express GATA-2 after birth either. When the number of skin mast cells was compared with the number of GATA-2 mRNA-expressing cells, GATA-2 mRNA appeared to be expressed by mast cells only when the number was EVELOPMENT of hematopoietic cells is controlled through the cooperative effects of growth factors that permit cellular proliferation and nuclear transcription factors that integrate the signals from growth factors and activate lineage specific genes.'.' For development of mast cells, the signals generated by binding of the stem cell factor (SCF) to the c-kit receptor tyrosine kinase is es~ential.~.~ Double gene dose of mutant alleles at either the SCF (SI) or the ckit (W) locus results in a deficiency of mast cells.'-" A lot of transcription factors probably are involved in development of mast cells, but only few of them have been reported to activate mast cell-specific genes.".'3
cell^.'^.'^ The GATA-2 gene is also expressed strongly by CMCs." Moreover, the GATA-2 transcription factor appears to play an important role for development of mast cells. Tsai et all5 targeted the GATA-2 gene in ES cells and showed the absence of SCF-responsive mast cell precursors in the GATA-2 gene-disrupted embryoid bodies.
The expression of GATA-binding transcription factors in mast cells has been investigated in CMCs and tumor mast cell lines''.'4," but not in mast cells located in animal tissues. In the present study, we examined the expression of the GATA-1 and GATA-2 genes in the skin of mice of various ages using in situ hybridization. Mast cells in the skin of mouse embryos strongly expressed the GATA-2 gene but not the GATA-1 gene between days 15 and 17 postcoitum (pc); the expression was downregulated on and after day 18 increasing. When the mRNA expression of high-affinity IgE receptor p-subunit and mast cell carboxypeptidase A was used as differentiation markers, the expression of these mRNAs continued even after the downregulation of GATA-2 expression. To clarify the relationship of the proliferation and GATA-2 expression, proliferating CMCs derived from WBB6Fl-+/+ mice were transplanted into the peritoneal cavity of mast cell-deficient WBB6Fl-W/ W mice. The CMCs stopped both the proliferation and GATA-2 expression after the transplantation, suggesting the association of these two parameters in mast cells within tissues of mice. 0 1996 by The American Society of Hematology.
pc. The timing of the GATA-2 gene expression was consistent with the rapid increase of mast cells in the skin of mouse embryos. Moreover, we found the downregulation of the GATA-2 gene expression in CMCs derived from the bone marrow (BM) of WBB6Fl-+/+ mice after the transplantation into the peritoneal cavity of WBB6FI-W/W" mice.
MATERIALS AND METHODS
Mice and mast cell number. WB-(+I+, W/+, SN+) mice were raised in our laboratory.8"o WBB6FI-WIW(W1W) and their normal littermate WBB6Fl-+/+ mice were purchased (Japan SLC CO Ltd, Hamamatsu, Japan). All of WlW, SUS1 and WIW mice are deficient in mast cells.8"0 Embryos of +I+ genotype were obtained by mating WB-+I+ parents. For embryonic staging, the day of vaginal plug observation was considered to be day 1 pc.'' WIW and SlIS1 mice and embryos were obtained by crossing WB-WI+ parents and WB-SW+ parents, respectively. Genotypes of WIW and SllSl embryos were determined according to Niwa et all9 The methods to count mast cells in skin tissues has been described.9320
Establishment of CMCs. Pokeweed mitogen-stimulated spleen cell conditioned medium ( P M -S C M ) was prepared as described by Nakahata et al. ' ' To obtain CMCs, mice of WB-(+l+, WIW) were killed on day 3 after birth by overinhalation of ether and spleens were procured. Because most SlISl embryos died before birth, spleens were obtained from embryos of days 17 to 19 pc. In an experiment, BM cells were obtained from 2-month-old WBB6F,-+/ Northern blot analysis and rever.se transcriprion-polymerasp chain reaction (RT-P CR) analysis. Total RNA was prepared from CMCs and skin tissues with the guanidine isothiocyanate method." Murine GATA-I, GATA-2, and &actin cDNA were used as probes after labeling with [3'P]-cr-deoxycytidine triphosphate by random oligonucleotide priming to do Northern blot analysis. Total RNA was prepared from skin tissues of WB-(+I+, WIW, S I N ) embryos of day 16 pc, CMCs and skin tissues of WB-+I+ mice of various ages (day 13 to 17 pc; 5 and 10 days after birth) and skin tissues of WIW mice of 1 day after birth. From 5 pg of total RNA, the single-strand cDNA was synthesized using reverse transcriptase (Boehringer Mannheim Biochemica, Mannheim, Germany) and random hexamer oligonucleotides (Promega, Madison, WI). cDNA was amplified by PCR using Taq DNA polymerase and each of specific primers (sense and antisense) for GATA-2, &actin, high-affinity receptor for the Fc portion of IgE (FctRI) P chain or mast cell carboxypeptidase A (MC-CPA). The following oligonucleotides were used for PCR: the GATA-2 sense primer CCCTAAGCAGCG-CAGCAAGAC and antisense primer TGACTTCTCCTGCAT-GCACT (101 2 through 1032 and 143 1 through 1450, respectively)2s; the mouse P-actin sense primer TAAAGACCTCTATGCCAACAC and the antisense primer CTCCTGCTTGCTGATCCACAT (950 through 970, and I143 through 1163, respectively)"; the mouse FctRI P-chain sense primer GAGCAGAGCAGATCTTGCTC and the antisense primer ATAAAGACGATCATCTGGGA (40 through 59, and 633 through 652, respectively)"; the mouse MC-CPA sense primer ACACAGGATCGAATGTGGAG and the antisense primer TAATGCAGGACTTCATGAGC (688 through 707, and 1358 through 1377, respectively).2x The PCR products were electrophoresed in agarose gel. DNA was stained with ethidium bromide on the gel.
In situ hybridization. Details of in situ hybridization technique have been described previ~usly.~~ An NCO I-digested 0.6-kb fragment of GATA-2 cDNA'~ was subcloned into EcoRV site of Bluescript pKS(-) vector, linealized, and transcribed to generate a cRNA probe. Digoxigenin-labeled single-strand RNA probes were prepared SlISl n n n for hybridization using a DIG RNA labeling kit (Boehringer) acwas recognized by the presence of dark brown granules on the cording to the manufacturer's instructions and the signals were denucleus." tected using the nucleic acid detection kit (Boehringer). The negative controls included (1) hybridization with the sense probes, (2) RNase treatment before hybridization, and (3) use of neither the antisense RNA probe nor the antidigoxygenin antibody. To evaluate whether CMCs were obtained from W-+/+ mice, and the expres- was either injected into the mice or was added into the culture was hardly detectable in the skin of 5 and 10-day-old Wmedium. In the former case, 50 pg/g body weight of BrdUrd was +/+ mice (Fig 1) . h contrast to the significant expression injected intravenously 1,3,7, and 14 days after the transplantation of of GATA-2 mRNA in the skin tissues of 15-to 17-day pc WBB6FI-+/+ mouse-derived CMCs (1.0 X lo') into the peritoneal embryos, the significant expression of GATA-1 mRNA was cavity of W / W mice. The mice were killed 60 minutes after the not detectable in the skin tissues of mice of all ages examined injection of BrdUrd, and the peritoneal cells were obtained. In the (Fig I) . Because the number of cells in the of latter case, the number of CMCs was adjusted to 3.0 X 104/mL; BrdUrd (3 pg/mL) was added 3 days after the adjustment, and CMCs embryonic mice increased in parallel with the ages,2" contri- (Fig 2A) , but the signal of GATA-2 mRNA was detectable in the skin of 16 day pc embryos of neither WIW nor SUS1 genotype even after the PCR amplification (Fig 2B) . Therefore, the depletion of GATA-2 mRNA in the skin of WB-WIW and WB-SUS1 embryos was attributed to the absence of mast cells. Because GATA-2 mRNA was not detectable in skin tissues of WB-W/ W and WB-SlISl embryos, mast cells appeared to be principal source of GATA-2 mRNA in skin tissues of WB-+/+ embryos. We confirmed this by in situ hybridization because the expression of GATA-2 mRNA has been reported in endothelial cells of blood vessels." Serial sections were cut from skin tissues of WB-+l+ mice of various ages. One section was stained with Alcian blue to count the number of mast cells and the other section was used for in situ hybridization of GATA-2 mRNA (Fig 3) . An appreciable number of mast cells and GATA-2 mRNA expressing cells were observed in the skin of WB-+/+ embryos from day 15 pc, and the expression of GATA-2 signals by some mast cells was confirmed by comparing two serial sections (Fig 3) . Because no GATA-2 mRNA-positive cells were found in the skin tissues of day 16 pc embryos of WB-WIW and WB-SllSl (data not shown), we considered that the GATA-2 mRNA-expressing cells in the skin of WB-+l+ embryos were mast cells. Therefore, the proportion of GATA-2 mRNA-expressing cells to Alcian blue-positive cells was assumed to be the proportion of mast cells that expressed GATA-2 mRNA. The proportion of mast cells that expressed GATA-2 mRNA was highest on day 15 pc (Table 1) . Although the number of mast cells continued to increase until day 18 pc, the proportion of mast cells that expressed GATA-2 mRNA started to decrease from day 16 pc. Only few GATA-2 mRNA-expressing mast cells were observed on and after day 18 pc (Table 1) . Despite the remarkable decrease in the proportion of GATA-2 mRNAexpressing mast cells on and after day 18 pc, most of all mast cells expressed MC-CPA mRNA throughout the observation period (data not shown). This suggested that the in situ hybridization technique used in the present study had sufficient sensitivity. The expression of GATA-2 was detectable in skin mast cells of WB-+/+ embryos only when the number of mast cells was increasing. Although CMCs proliferate in culture, they stop the proliferation after injection into the peritoneal cavity of WBB6F,-WIWV mice.3' We obtained CMCs from the BM of WBB6Fl-+I+ mice and injected them into the peritoneal cavity of WBB6FI-WIW" mice. Then proportion of mast cells in the S phase of the cell cycle and the proportion of mast cells with GATA-2 mRNA were determined. Most of the CMCs maintained in suspension culture expressed GATA-2 before injection by in situ hybridization ( Table 2 ). The proportion of mast cells in S phase and that of GATA-2-expressing mast cells gradually decreased after the injection and dropped to the levels observed in peritoneal mast cells obtained from intact WBB6FI-+/+ mice on day 14 after the injection (Table 2) .
Because mast cells express FceRI and MC-CPA ~R N A s , '~.~* we used the expression of these genes in the skin tissues of mice of various ages as differentiation markers. As expected, CMCs derived from WB-+/+ mice expressed both FceRI &subunit and MC-CPA mRNAs, but mRNAs of both FcrRI &subunit and MC-CPA were not detectable in the skin tissue of WIW mice even after the PCR amplification (Fig 4) . Both FcrRI P-subunit and MC-CPA mRNAs were not detectable in the skin tissue of day 13 pc WB-+/+ embryos, in which no mast cells were detectable with Alcian blue staining (Fig 4) . However, on and after day 14 pc both mRNAs were detectable in skin tissues throughout the observation period. The continuous expression of FceRI P-subunit and MC-CPA mRNAs was in a striking contrast to the apparent drop of GATA-2 mRNA expression observed on day 18 pc (Figs 1 and 4) .
DISCUSSION
Expression of GATA-1 and GATA-2 mRNAs were examined in CMCs and skin tissues of mice. By Northern blot analysis, CMCs strongly expressed both GATA-I and GATA-2 mRNAs whereas skin tissues of WB-+/+ embryos expressed only GATA-2 mRNA. Because skin tissues of mast cell-deficient WIW and SNSI embryos did not express 997 GATA-2 mRNA, the GATA-2 mRNA was most likely to be derived from mast cells. Moreover, the presence of GATA-2 mRNA in skin mast cells was confirmed by in situ hybridization. No GATA-2 mRNA containing cells were detectable in the skin of WIW and SIISI embryos. The abundant expression of GATA-2 mRNA in developing mast cells in mouse embryos is consistent with the results obtained using ES cells in which either GATA-I or GATA-2 gene was di~rupted.'~"~ Mast cells can develop from GATA-1 -disrupted embryoid bodiesI7 but not from GATA-2-disrupted embryoid bodies.Is
Mast cells were first detectable in the skin of WB-+/+ mouse embryos on day 14 pc, and the number of mast cells rapidly increased until day 18 pc. When the number of mast cells reached to the maximal level, the expression of GATA-2 mRNA ceased abruptly. This is reminiscent of an association of the increase in number with the expression of GATA-2 in embryonic skin mast cells. We examined this possibility by injecting GATA-2-expressing CMCs into the peritoneal cavity of mast cell-deficient W / W mice. CMCs kept in suspension culture proliferated and most of them expressed GATA-2 mRNA. However, after the transplantation CMCs stopped both proliferation and GATA-2 expression. Briegel et a1'3 reported that overexpression of GATA-2 promoted proliferation in chicken erythroid cells. This is consistent with our results in mast cells. Because the transplanted CMCs acquired mature phenotypes in the peritoneal cavity,2"'2 abundant expression of GATA-2 mRNA appeared to be necessary in developing, but not in mature mast cells.
FccRI P-subunit and MC-CPA are good differentiation markers of mast cells.'J"h Moreover, the transcriptional regulation of the MC-CPA gene by GATA-binding factors has been reported." Because all GATA-2, FcrRI P-subunit, and MC-CPA mRNAs were expressed soon after the appearence of mast cells themselves, we could not conclude that the GATA-2 factor initiated the expression of MC-CPA not only in vitro but also in vivo. Because a GATA-binding motif is present in 5"flanking resion of FcrRI P-subunit gene:7 there is a possibility that the GATA-2 factor may play a role for the initiation of its transcription. However, because the expression of FceRI &subunit and MC-CPA genes continued even after the drop of the GATA-2 gene expression, the high level expression of GATA-2 gene may not be necessary for keeping differentiation state of mast cells.
